NCT03770910

The Effect of GIP(3-30)NH2

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: University Hospital, Gentofte, Copenhagen · Academic / Other
• Sex: Male
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Infusion of glucose-dependent insulintropic polypeptide (GIP) receptor antagonist and evaluation of effect of insulin secretion in healthy subjects.

Detailed description

Infusion of glucose-dependent insulintropic polypeptide (GIP) receptor antagonist and evaluation of effect of insulin secretion in healthy subjects. Six study hyperglycemic clamps (10 mmol/l) pr. participant.

Conditions

• Endocrine - Other

Interventions

Type	Name	Description
OTHER	GIP receptor antagonist	GIP receptor antagonist
OTHER	GIP receptor agonist	GIP(1-42)
OTHER	Saline	Placebo (vehicle for infusions)

Timeline

• Start date: 2018-12-06
• Primary completion: 2019-03-01
• Completion: 2019-12-01
• First posted: 2018-12-10
• Last updated: 2020-03-26

Locations

2 sites across 1 country: Denmark